Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.
暂无分享,去创建一个
R. D. du Bois | M. Selman | K. Brown | L. Richeldi | V. Cottin | R. Schlenker‐Herceg | S. Stowasser | Z. Bailes | T. Kimura